FLNT.NASDAQFluent, INC

SCHEDULE: Frost Gamma Boosts Fluent Inc. Stake to 28.3% with $1M Warrant Purchase

Sentiment:

Beneficial Ownership Update


Phillip Frost, M.D. and Frost Gamma Investments Trust increased their beneficial ownership in Fluent, Inc. to 28.3% through a $1 million purchase of pre-funded warrants and warrants.

Capital raiseGamma Trust subscribed for $1,000,000 aggregate amount of Unregistered Pre-Funded Warrants and Warrants from Fluent, Inc.The aggregate exercise price of the Unregistered Pre-Funded Warrants was pre-funded, providing immediate capital to the company.

Summary

  • Phillip Frost, M.D. and Frost Gamma Investments Trust (collectively, the "Reporting Person") filed Amendment No. 26 to their Schedule 13D for Fluent, Inc.
  • The Reporting Person now beneficially owns 7,302,737 shares of Fluent, Inc. common stock, representing 28.3% of the outstanding shares.
  • This ownership includes 66,667 shares underlying a Convertible Note, 909,297 shares from warrants issued on May 19, 2025, and 571,429 shares from Unregistered Pre-Funded Warrants acquired on August 19, 2025.
  • On August 19, 2025, Gamma Trust entered into a Securities Purchase Agreement with Fluent, Inc. to subscribe for $1,000,000 worth of Unregistered Pre-Funded Warrants and Warrants.
  • The Unregistered Pre-Funded Warrants were purchased at $1.75 each with a nominal exercise price of $0.0005, and their aggregate exercise price was pre-funded.
  • The Warrants have an exercise price of $2.21 per share and become exercisable six months and one day after issuance, for a period of five years.
  • In connection with this transaction, a Support Agreement was signed, obligating the Reporting Person to vote in favor of certain stockholder-approved actions and against actions that would impede the Purchase Agreement.
  • A Registration Rights Agreement was also executed, requiring Fluent, Inc. to file a registration statement for the resale of certain securities.
  • The beneficial ownership percentage is based on 24,268,299 shares of common stock outstanding as of August 18, 2025.

Sentiment

Score: 7

Explanation: The filing indicates a significant insider investment and a commitment to support the company, which is generally positive. However, the potential for future dilution from warrants and the lack of specific operational updates temper the enthusiasm.

Positives

  • The $1,000,000 investment by Frost Gamma Investments Trust provides capital to Fluent, Inc.
  • The Support Agreement indicates a commitment from a significant shareholder (Phillip Frost, M.D.) to support certain corporate actions, potentially providing stability.
  • The increase in beneficial ownership by a long-term investor like Dr. Frost could signal confidence in the company's future.

Negatives

  • The issuance of warrants and pre-funded warrants could lead to future dilution for existing shareholders if exercised.
  • The Support Agreement restricts the Reporting Person's voting flexibility on certain matters.

Risks

  • Dilution Risk: Exercise of the Unregistered Pre-Funded Warrants and Warrants will increase the number of outstanding shares, potentially diluting the value of existing common stock.
  • Market Price Volatility: The value of the warrants is tied to the future market price of Fluent, Inc. common stock, which can be volatile.
  • Registration Statement Risk: The company is required to file a registration statement, which involves costs and regulatory compliance.

Future Outlook

The filing indicates a long-term commitment from a significant shareholder through the acquisition of warrants and a support agreement, suggesting an expectation of future growth or stability for Fluent, Inc. The requirement for Fluent, Inc. to file a registration statement for resale of securities also points to future market activity.

Industry Context

This filing reflects a significant insider investment in a company, which can be seen as a positive signal in the ad-tech or data analytics industry where Fluent, Inc. operates. Such investments often occur when insiders believe the company is undervalued or has strong growth prospects, potentially contrasting with broader market sentiment or industry-specific challenges.

Comparison to Industry Standards

  • The 28.3% beneficial ownership by Dr. Frost and Gamma Trust is a substantial stake, indicating a high level of insider control and influence, which is higher than typical institutional investor stakes in many publicly traded companies.
  • The capital infusion of $1 million, while not massive for a public company, is significant in the context of the company's market capitalization and could be compared to similar strategic investments or private placements in the ad-tech sector.
  • The terms of the warrants (exercise price, duration) are standard for such instruments, but their pre-funded nature for a portion of the investment is a common mechanism to provide immediate capital while deferring full equity issuance.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Voting AgreementThe Reporting Person entered into a Support Agreement, agreeing to vote beneficially owned shares in favor of certain actions subject to Stockholder Approval and against proposals that would breach the Purchase Agreement or impede its consummation.2025-08-19Enhances stability for certain corporate actions but limits the voting discretion of a major shareholder on specific matters related to the Purchase Agreement.

Related Party Transactions

  • The transaction involves Phillip Frost, M.D. and Frost Gamma Investments Trust, which are related parties to Fluent, Inc. given Dr. Frost's significant beneficial ownership and historical involvement. The purchase of warrants and the associated agreements constitute a related party transaction.

Stakeholder Impact

  • Shareholders: Potential for dilution from warrant exercise; increased insider confidence could be positive; voting agreement impacts corporate governance.
  • Company (Fluent, Inc.): Receives $1,000,000 in capital; gains a commitment from a major shareholder to support certain corporate actions.
  • Creditors: The capital infusion could improve the company's financial position, potentially benefiting creditors.

Next Steps

  • Fluent, Inc. is required to file a registration statement covering the resale of certain Registrable Securities as per the Registration Rights Agreement.
  • The Warrants will become exercisable six months and one day following their issuance date.

Key Dates

DateDescription
2007-12-06Initial Schedule 13D filed.
2024-08-19Date of Convertible Note agreement.
2025-05-19Date warrants were issued.
2025-08-18Date for which 24,268,299 shares of common stock were outstanding, as reported in the Issuer's Form 10-Q.
2025-08-19Date of event requiring filing of this statement; Gamma Trust entered into a Securities Purchase Agreement, Support Agreement, and Registration Rights Agreement with Fluent, Inc.; closing of sales of Unregistered Pre-Funded Warrants and Warrants occurred.
2025-08-26Date of signing of the Joint Filing Agreement and the Schedule 13D Amendment No. 26.

Recommendation

hold

The significant insider investment and capital infusion are positive signals, indicating confidence from a major shareholder. However, the potential for future dilution from the warrants and the lack of new operational or financial performance data suggest a "hold" position until more comprehensive information is available to assess the long-term impact and company trajectory. The transaction primarily reflects a financing event and an ownership update rather than a fundamental shift in business operations.

Keywords

Fluent Inc., FLNT, Phillip Frost, Frost Gamma Investments Trust, Schedule 13D, Beneficial Ownership, Warrants, Pre-Funded Warrants, Securities Purchase Agreement, Support Agreement, Registration Rights Agreement, Capital Raise, Dilution

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.